Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Esketamine dose levels combined with dexmedetomidine to reduce pain after scoliosis correction

Official title: Impact of Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia on Long-term Outcomes After Scoliosis Correction Surgery: Follow-up of a Randomized Trial

Run by Peking University First Hospital · NCT06087510 · Data updated 2026-11-12

This study will test whether different doses of esketamine given with dexmedetomidine and opioids can reduce immediate postoperative pain and lower the chance of chronic postsurgical pain in adults having scoliosis correction.

More Dexmedetomidine trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment312 (estimated)
SponsorPeking University First Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJanuary 24, 2024
Main results expectedDecember 2025
Study endsSeptember 2026
Registry record updatedJuly 30, 2025
Trial IDNCT06087510 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 years or older, weighing at least 40 kg, scheduled for scoliosis correction with pedicle screw fixation and requiring postoperative patient-controlled IV analgesia are the intended participants.

Probably not a fit

Patients with severe cardiovascular disease, significant obstructive sleep apnea, certain psychiatric or neurologic disorders, severe liver or renal dysfunction, or other listed exclusion conditions would be ineligible and unlikely to benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults scheduled for scoliosis correction with pedicle screw fixation who require patient-controlled intravenous analgesia will be assigned to receive different doses of esketamine combined with dexmedetomidine as supplemental postoperative analgesia. The study compares pain scores, opioid consumption, sleep quality, and the occurrence of chronic postsurgical pain over follow-up. Esketamine is used for its NMDA-antagonist antihyperalgesic effects while dexmedetomidine provides sedative and analgesic adjunct effects. Outcomes focus on both short-term analgesia and longer-term pain measured at least three months after surgery.

Why it matters

Potential benefit: If successful, this approach could improve acute pain control, reduce opioid needs, and lower the risk of long-term chronic postsurgical pain after scoliosis surgery.

How similar studies have gone: Previous work found that a mini-dose esketamine–dexmedetomidine combination improved analgesia and sleep but did not reduce chronic postsurgical pain, while other studies of perioperative ketamine/esketamine have shown mixed results depending on patient populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged ≥18 years and body weight≥40 kg;
* Scheduled to undergo scoliosis correction with pedicle screw fixation;
* Required patient-controlled intravenous analgesia (PCIA) after surgery.

Exclusion Criteria:

* Preoperative sick sinus syndrome, severe sinus bradycardia (heart rate \<50 beats per minute), atrioventricular block grade II or above without pacemaker, congenital heart disease, arrhythmia, or other serious cardiovascular diseases with a New York Heart Association class ≥III;
* Patients with moderate or severe obstructive sleep apnea diagnosed preoperatively or according to the STOP-Bang score;
* History of hyperthyroidism or pheochromocytoma;
* History of schizophrenia, epilepsy, myasthenia gravis;
* Severe liver dysfunction (Child-Pugh grade C), severe renal dysfunction (preoperative dialysis), or American Society of Anaesthesiologists grade ≥IV;
* Barrier in communication;
* Other conditions that were considered unsuitable for study participation.

Where it's running

  • Beijing University First Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.